Ral overactivation in malignant peripheral nerve sheath tumors.

Standard

Ral overactivation in malignant peripheral nerve sheath tumors. / Vidya, Bodempudi; Yamoutpoor, Farnaz; Pan, Weihong; Dudek, Arkadiusz Z; Esfandyari, Tuba; Piedra, Mark; Babovick-Vuksanovic, Dusica; Woo, Richard A; Mautner, Viktor Felix; Kluwe, Lan; Vries, De; George, H; Thomas, Stacey L; Kurtz, Andreas; Parada, Luis F; Farassati, Faris.

in: MOL CELL BIOL, Jahrgang 29, Nr. 14, 14, 2009, S. 3964-3974.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Vidya, B, Yamoutpoor, F, Pan, W, Dudek, AZ, Esfandyari, T, Piedra, M, Babovick-Vuksanovic, D, Woo, RA, Mautner, VF, Kluwe, L, Vries, D, George, H, Thomas, SL, Kurtz, A, Parada, LF & Farassati, F 2009, 'Ral overactivation in malignant peripheral nerve sheath tumors.', MOL CELL BIOL, Jg. 29, Nr. 14, 14, S. 3964-3974. <http://www.ncbi.nlm.nih.gov/pubmed/19414599?dopt=Citation>

APA

Vidya, B., Yamoutpoor, F., Pan, W., Dudek, A. Z., Esfandyari, T., Piedra, M., Babovick-Vuksanovic, D., Woo, R. A., Mautner, V. F., Kluwe, L., Vries, D., George, H., Thomas, S. L., Kurtz, A., Parada, L. F., & Farassati, F. (2009). Ral overactivation in malignant peripheral nerve sheath tumors. MOL CELL BIOL, 29(14), 3964-3974. [14]. http://www.ncbi.nlm.nih.gov/pubmed/19414599?dopt=Citation

Vancouver

Vidya B, Yamoutpoor F, Pan W, Dudek AZ, Esfandyari T, Piedra M et al. Ral overactivation in malignant peripheral nerve sheath tumors. MOL CELL BIOL. 2009;29(14):3964-3974. 14.

Bibtex

@article{92f1ecf5b61a4bdd8a773379080e35cf,
title = "Ral overactivation in malignant peripheral nerve sheath tumors.",
abstract = "Ras leads an important signaling pathway that is deregulated in neurofibromatosis type 1 and malignant peripheral nerve sheath tumor (MPNST). In this study, we show that overactivation of Ras and many of its downstream effectors occurred in only a fraction of MPNST cell lines. RalA, however, was overactivated in all MPNST cells and tumor samples compared to nontransformed Schwann cells. Silencing Ral or inhibiting it with a dominant-negative Ral (Ral S28N) caused a significant reduction in proliferation, invasiveness, and in vivo tumorigenicity of MPNST cells. Silencing Ral also reduced the expression of epithelial mesenchymal transition markers. Expression of the NF1-GTPase-related domain (NF1-GRD) diminished the levels of Ral activation, implicating a role for neurofibromin in regulating RalA activation. NF1-GRD treatment caused a significant decrease in proliferation, invasiveness, and cell cycle progression, but cell death increased. We propose Ral overactivation as a novel cell signaling abnormality in MPNST that leads to important biological outcomes with translational ramifications.",
author = "Bodempudi Vidya and Farnaz Yamoutpoor and Weihong Pan and Dudek, {Arkadiusz Z} and Tuba Esfandyari and Mark Piedra and Dusica Babovick-Vuksanovic and Woo, {Richard A} and Mautner, {Viktor Felix} and Lan Kluwe and De Vries and H George and Thomas, {Stacey L} and Andreas Kurtz and Parada, {Luis F} and Faris Farassati",
year = "2009",
language = "Deutsch",
volume = "29",
pages = "3964--3974",
journal = "MOL CELL BIOL",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "14",

}

RIS

TY - JOUR

T1 - Ral overactivation in malignant peripheral nerve sheath tumors.

AU - Vidya, Bodempudi

AU - Yamoutpoor, Farnaz

AU - Pan, Weihong

AU - Dudek, Arkadiusz Z

AU - Esfandyari, Tuba

AU - Piedra, Mark

AU - Babovick-Vuksanovic, Dusica

AU - Woo, Richard A

AU - Mautner, Viktor Felix

AU - Kluwe, Lan

AU - Vries, De

AU - George, H

AU - Thomas, Stacey L

AU - Kurtz, Andreas

AU - Parada, Luis F

AU - Farassati, Faris

PY - 2009

Y1 - 2009

N2 - Ras leads an important signaling pathway that is deregulated in neurofibromatosis type 1 and malignant peripheral nerve sheath tumor (MPNST). In this study, we show that overactivation of Ras and many of its downstream effectors occurred in only a fraction of MPNST cell lines. RalA, however, was overactivated in all MPNST cells and tumor samples compared to nontransformed Schwann cells. Silencing Ral or inhibiting it with a dominant-negative Ral (Ral S28N) caused a significant reduction in proliferation, invasiveness, and in vivo tumorigenicity of MPNST cells. Silencing Ral also reduced the expression of epithelial mesenchymal transition markers. Expression of the NF1-GTPase-related domain (NF1-GRD) diminished the levels of Ral activation, implicating a role for neurofibromin in regulating RalA activation. NF1-GRD treatment caused a significant decrease in proliferation, invasiveness, and cell cycle progression, but cell death increased. We propose Ral overactivation as a novel cell signaling abnormality in MPNST that leads to important biological outcomes with translational ramifications.

AB - Ras leads an important signaling pathway that is deregulated in neurofibromatosis type 1 and malignant peripheral nerve sheath tumor (MPNST). In this study, we show that overactivation of Ras and many of its downstream effectors occurred in only a fraction of MPNST cell lines. RalA, however, was overactivated in all MPNST cells and tumor samples compared to nontransformed Schwann cells. Silencing Ral or inhibiting it with a dominant-negative Ral (Ral S28N) caused a significant reduction in proliferation, invasiveness, and in vivo tumorigenicity of MPNST cells. Silencing Ral also reduced the expression of epithelial mesenchymal transition markers. Expression of the NF1-GTPase-related domain (NF1-GRD) diminished the levels of Ral activation, implicating a role for neurofibromin in regulating RalA activation. NF1-GRD treatment caused a significant decrease in proliferation, invasiveness, and cell cycle progression, but cell death increased. We propose Ral overactivation as a novel cell signaling abnormality in MPNST that leads to important biological outcomes with translational ramifications.

M3 - SCORING: Zeitschriftenaufsatz

VL - 29

SP - 3964

EP - 3974

JO - MOL CELL BIOL

JF - MOL CELL BIOL

SN - 0270-7306

IS - 14

M1 - 14

ER -